Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $265 thousand versus the consensus estimate of $439.67 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.